Japanese pharmaceutical company Shionogi has lifted its full-year profit guidance as expected royalties from its HIV treatment surpass prior expectations. https://www.japantimes.co.jp/business/2025/10/28/shionogi-raises-profit-outlook/?utm_medium=Social&utm_source=mastodon #business #shionogi #hiv #pharmaceutical
Shionogi lifts profit outlook on HIV royalties and overseas growth

The company raised its full-year operating profit by 5.7% to ¥185 billion, beating analyst estimates.

The Japan Times
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
Asian pharma stocks tumble on Trump signal to cut U.S. drug prices

The U.S. president's social media post put pressure on drug-related stocks on worries their profits will take a hit if they have to reduce prices in the U.S.

The Japan Times

corriere.it by Isidoro Trovato
Shionogi, l’alleato giapponese per combattere una nuova emergenza sanitaria

Quella nipponica è è tra le poche aziende farmaceutiche che continuano a dedicare risorse alla ricerca e sviluppo di antinfettivi. Con l’Italia può nascere un connubio fondamentale. A patto che...

Translated:
Shionogi, the Japanese ally in fighting a new health emergency.

That Japanese company is one of the few pharmaceutical companies that continue to dedicate resources to the research and development of anti-infectives. With Italy, a fundamental partnership can be born. Provided that...

#Japan #Italy #Shionogi
https://www.corriere.it/economia/professionisti/medici/24_settembre_17/shionogi-l-alleato-giapponese-per-combattere-una-nuova-emergenza-sanitaria-0b99cb93-ecf8-4586-be5e-6e47969a8xlk.shtml

Shionogi, l’alleato giapponese per combattere una nuova emergenza sanitaria

Quella nipponica è è tra le poche aziende farmaceutiche che continuano a dedicare risorse alla ricerca e sviluppo di antinfettivi. Con l’Italia può nascere un connubio fondamentale. A patto che...

Corriere della Sera
Shionogi brings generative AI to medical conferences with 'Warrior' portrait campaign

Shionogi is bringing AI warriors to life at medical conferences. With the help of ad agency FCBCURE, the biopharma added generative artificial intelligence to its already-running infectious disease “Warriors” campaign to create personalized images for people at medical conferences. Medical professionals can step into the photo booth — first unveiled

Endpoints News
Europe on the frontline in the fight against AMR

With collective determination, an open mindset and willingness to do things dif

EURACTIV
Japan panel endorses first domestically developed COVID vaccine

The shot is based on the original strain of the coronavirus, making it unlikely that it will be used in Japan or elsewhere.

The Japan Times
» 11月24日 #COVID19 説明会 - プレゼンテーション資料 | 塩野義製薬 https://t.co/RtmEvvjByo
#Shionogi https://t.co/mNYV7Yza4F
» 新型コロナウイルス感染症(#COVID19 )ワクチンS-268019の国内における製造販売承認申請について|シオノギ製薬(塩野義製薬) https://t.co/Z7pxJbfwWF // この度の製造販売承認申請は、国内で実施した5つの臨床試験の良好な結果に基づくものです1-5。
#Shionogi
新型コロナウイルス感染症(COVID-19)ワクチンS-268019の国内における製造販売承認申請について